Literature DB >> 16418738

Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi.

Francesca R Grati1, Beatrice Grimi, Giuditia Frascoli, Anna Maria Di Meco, Rosaria Liuti, Silvia Milani, Anna Trotta, Francesca Dulcetti, Enrico Grosso, Monica Miozzo, Federico Maggi, Giuseppe Simoni.   

Abstract

Chromosome mosaicism is detected in about 1-2% of chorionic villi samples (CVS), and may be due to a postzygotic nondisjunction event generating a trisomic cell line in an initially normal conceptus (mitotic origin) or the postzygotic loss of one chromosome in an initially trisomic conceptus (meiotic origin and trisomy rescue). Depending on the distribution of the abnormal cell line, the mosaic can be confined to the placenta (CPM) or generalised to the fetus (TFM, true fetal mosaicism). Trisomy rescue could theoretically be associated with a 33.3% probability of uniparental disomy (UPD) in the fetus. The aim of this study was to determine the risk of fetal involvement in a cohort of numerical and structural chromosome mosaics revealed in chorionic villi by means of combined direct and long-term culture analyses; we also determined the incidence of UPD associated with mosaic aneuploidies and supernumerary markers involving imprinted chromosomes. A total of 273 of a consecutive series of 15,109 CVS evaluated during a period of 5 years showed a mosaic condition in direct preparations and/or long-term cultures; confirmatory amniocentesis was performed in 203 cases. The abnormal cell line was extended to the fetus in 12.8% cases in terms of structural and numerical abnormalities involving autosomes and sex chromosomes; the risk of TFM varied and depended on the placental tissue distribution of the abnormal cell line. One of the 51 cases in which the mosaic involved an imprinted chromosome showed UPD, thus indicating a risk of 1.96%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418738     DOI: 10.1038/sj.ejhg.5201564

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Detection of chromosome aneuploidies in chorionic villus samples by multiplex ligation-dependent probe amplification.

Authors:  Angelique J A Kooper; Brigitte H W Faas; Ton Feuth; Johan W T Creemers; Hans H Zondervan; Peter F Boekkooi; Rik W P Quartero; Robbert J P Rijnders; Ineke van der Burgt; Ad Geurts van Kessel; Arie P T Smits
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

Review 2.  Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.

Authors:  E S Taglauer; L Wilkins-Haug; D W Bianchi
Journal:  Placenta       Date:  2013-12-01       Impact factor: 3.481

3.  Intrauterine growth retardation associated with precocious puberty and sertoli cell hyperplasia.

Authors:  M B Lodish; L A Gartner; P Albini; G Sabnis; A Brodie; J M Meck; A M Meloni-Ehrig; S Hill; E Tsilou; V A Valera; B A Walter; M J Merino; C A Stratakis
Journal:  Horm Metab Res       Date:  2010-04-21       Impact factor: 2.936

4.  Evidence-based clinical prioritization of embryos with mosaic results: a systematic review and meta-analysis.

Authors:  Ali Mourad; Roland Antaki; François Bissonnette; Obey Al Baini; Boutros Saadeh; Wael Jamal
Journal:  J Assist Reprod Genet       Date:  2021-09-02       Impact factor: 3.412

5.  Chromosome 12q24.31-q24.33 deletion causes multiple dysmorphic features and developmental delay: First mosaic patient and overview of the phenotype related to 12q24qter defects.

Authors:  Jawaher Al-Zahrani; Naji Al-Dosari; Nada Abudheim; Tarfa A Alshidi; Dilek Colak; Ola Al-Habit; Ali Al-Odaib; Nadia Sakati; Brian Meyer; Pinar T Ozand; Namik Kaya
Journal:  Mol Cytogenet       Date:  2011-04-02       Impact factor: 2.009

6.  Is routine karyotyping required in prenatal samples with a molecular or metabolic referral?

Authors:  Angelique Ja Kooper; Jacqueline Jpm Pieters; Brigitte Hw Faas; Lies H Hoefsloot; Ineke van der Burgt; Hans A Zondervan; Arie Pt Smits
Journal:  Mol Cytogenet       Date:  2012-01-27       Impact factor: 2.009

7.  Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance.

Authors:  Robert W Old; Jonathan P Bestwick; Nicholas J Wald
Journal:  F1000Res       Date:  2017-10-27

Review 8.  Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis.

Authors:  Francesca Romana Grati
Journal:  J Clin Med       Date:  2014-07-24       Impact factor: 4.241

9.  The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts.

Authors:  Veronica Novik; Emily B Moulton; Michael E Sisson; Shagun L Shrestha; Khoa D Tran; Harvey J Stern; Brian D Mariani; Wayne S Stanley
Journal:  Mol Cytogenet       Date:  2014-02-28       Impact factor: 2.009

10.  Causal variants screened by whole exome sequencing in a patient with maternal uniparental isodisomy of chromosome 10 and a complicated phenotype.

Authors:  Niu Li; Y U Ding; Tingting Yu; Juan Li; Yongnian Shen; Xiumin Wang; Qihua Fu; Yiping Shen; Xiaodong Huang; Jian Wang
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.